DCLK1 and colorectal carcinoma: Similarly, suppression of DCLK1-B expression in patient-derived CRC cells (hCRC#1, Figure S3F-G) by small interfering RNAs (siRNAs) attenuated CRC aggressiveness (Figure S3H-J).